1. Home
  2. INTZ vs RNTX Comparison

INTZ vs RNTX Comparison

Compare INTZ & RNTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INTZ
  • RNTX
  • Stock Information
  • Founded
  • INTZ 1983
  • RNTX 2001
  • Country
  • INTZ United States
  • RNTX United States
  • Employees
  • INTZ N/A
  • RNTX N/A
  • Industry
  • INTZ Computer Communications Equipment
  • RNTX Biotechnology: Pharmaceutical Preparations
  • Sector
  • INTZ Telecommunications
  • RNTX Health Care
  • Exchange
  • INTZ Nasdaq
  • RNTX Nasdaq
  • Market Cap
  • INTZ 31.8M
  • RNTX 28.0M
  • IPO Year
  • INTZ 2020
  • RNTX N/A
  • Fundamental
  • Price
  • INTZ $1.81
  • RNTX $1.47
  • Analyst Decision
  • INTZ Buy
  • RNTX Buy
  • Analyst Count
  • INTZ 2
  • RNTX 2
  • Target Price
  • INTZ $7.00
  • RNTX $10.00
  • AVG Volume (30 Days)
  • INTZ 235.3K
  • RNTX 236.3K
  • Earning Date
  • INTZ 11-07-2025
  • RNTX 11-13-2025
  • Dividend Yield
  • INTZ N/A
  • RNTX N/A
  • EPS Growth
  • INTZ N/A
  • RNTX N/A
  • EPS
  • INTZ N/A
  • RNTX N/A
  • Revenue
  • INTZ $6,828,000.00
  • RNTX N/A
  • Revenue This Year
  • INTZ $36.75
  • RNTX N/A
  • Revenue Next Year
  • INTZ $30.90
  • RNTX N/A
  • P/E Ratio
  • INTZ N/A
  • RNTX N/A
  • Revenue Growth
  • INTZ 25.86
  • RNTX N/A
  • 52 Week Low
  • INTZ $0.35
  • RNTX $1.04
  • 52 Week High
  • INTZ $7.34
  • RNTX $4.40
  • Technical
  • Relative Strength Index (RSI)
  • INTZ 51.09
  • RNTX 68.96
  • Support Level
  • INTZ $1.58
  • RNTX $1.13
  • Resistance Level
  • INTZ $1.87
  • RNTX $1.21
  • Average True Range (ATR)
  • INTZ 0.12
  • RNTX 0.10
  • MACD
  • INTZ 0.01
  • RNTX 0.02
  • Stochastic Oscillator
  • INTZ 52.38
  • RNTX 86.67

About INTZ Intrusion Inc.

Intrusion Inc is a cybersecurity company based in Plano, Texas. The group offers customers to access its threat intelligence database containing the historical data, known associations, and reputational behavior of Internet Protocol (IP) addresses. The company's product consists of On-Premise Network Protection, Cyber Threat Consulting, Cloud Network Security, and Endpoint Protection. Its solutions are INTRUSION Shield, INTRUSION TraceCop, and INTRUSION Savant. Its end-user customers include the U.S. federal government, state and local government entities, large and diversified conglomerates, and manufacturing entities.

About RNTX Rein Therapeutics Inc. Common Stock

Rein Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on developing therapies in orphan pulmonary and fibrosis indications, including two Phase 2-ready clinical assets. The company's product candidate includes LTI-03: a peptide for which company conducted a Phase 1b dose-ranging, placebo-controlled safety, tolerability, and pharmacodynamic biomarker activity trial in development for the treatment of Idiopathic Pulmonary Fibrosis; LTI-01: proenzyme that completed a Phase 2a dose-ranging, placebo-controlled trial and a Phase 1b safety, tolerability and proof of mechanism trial in loculated pleural effusion, or LPE, patients, an indication that has no approved drug treatment; and LTI-05 and others.

Share on Social Networks: